ReviewClinical parkinsonism & related disorders2025
Time to add two new disorders to neuropsychiatric aspects of Parkinson's disease.
Review in Clinical parkinsonism & related disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent reviews have explored Parkinson's Disease (PD) through psychiatric lenses. However, emerging literature allows to go beyond psychosis, depression, and impulse control disorders. Two key emerging themes are prominent: firstly, studies accrued in the past 13 years challenge prevailing views by demonstrating Somatic Symptom Disorders/Somatoform Disorders (SSD-SD) significantly participate in the PD phenotype, with relevant treatment implications. Secondly, epidemiological data reveal a link between Bipolar Spectrum Disorders (BSD) and PD, prompting a reconsideration of Impulse Control Disorder/Hedonistic Homeostatic Dysregulation (ICD/HHD) in PD. Furthermore, behaviors akin to BSD symptoms during manic states are observed in PD, suggesting shared neurobiological underpinnings. Our proposed review tackles these themes, dissecting the impact of SSD-SD on PD and highlighting the BSD-PD convergence. This approach has implications for tailored psychotherapeutic techniques targeting psychosomatic and functional neurologic disorders within the context of PD care. Moreover, recognizing the blurred lines between neurology and psychiatry in PD underscores the importance of a holistic, interdisciplinary approach. As these findings challenge established assumptions and offer new avenues for patient care, we must promote our understanding of PD's intricate neuropsychiatric dimensions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.